.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Agouron Company Profile

« Back to Dashboard

Summary for Applicant: Agouron

Patents:0
Tradenames:1
Ingredients:1
NDAs:3
Drug Master File Entries: 0
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Agouron
VIRACEPT
nelfinavir mesylate
POWDER;ORAL020778-001Mar 14, 1997DISCNNo<disabled><disabled>
Agouron
VIRACEPT
nelfinavir mesylate
TABLET;ORAL020779-001Mar 14, 1997RXYes<disabled><disabled>
Agouron
VIRACEPT
nelfinavir mesylate
TABLET;ORAL021503-001Apr 30, 2003RXYes<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

`abc